Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Amit, Druyan"'
Autor:
Abdulla Watad, Gabriele De Marco, Hussein Mahajna, Amit Druyan, Mailam Eltity, Nizar Hijazi, Amir Haddad, Muna Elias, Devy Zisman, Mohammad E. Naffaa, Michal Brodavka, Yael Cohen, Arsalan Abu-Much, Muhanad Abu Elhija, Charlie Bridgewood, Pnina Langevitz, Joanna McLorinan, Nicola Luigi Bragazzi, Helena Marzo-Ortega, Merav Lidar, Cassandra Calabrese, Leonard Calabrese, Edward Vital, Yehuda Shoenfeld, Howard Amital, Dennis McGonagle
Publikováno v:
Vaccines, Vol 9, Iss 5, p 435 (2021)
Background: Infectious diseases and vaccines can occasionally cause new-onset or flare of immune-mediated diseases (IMDs). The adjuvanticity of the available SARS-CoV-2 vaccines is based on either TLR-7/8 or TLR-9 agonism, which is distinct from prev
Externí odkaz:
https://doaj.org/article/3c02d7fb0a1f4615882281e1e3069417
Publikováno v:
Skeletal Radiology. 51:1595-1601
To evaluate the frequency of sacroiliitis in older subjects.Consecutive MRI examinations of the sacroiliac joints (SIJs) performed for suspected sacroiliitis (2005-2019) in patients ≥ 18 years were retrospectively evaluated for the presence of acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7828aaac078e0cf752fc7e257f2c2a8
https://doi.org/10.1007/s00256-022-04001-z
https://doi.org/10.1007/s00256-022-04001-z
Publikováno v:
Clinical and Experimental Rheumatology. 39:75-79
To evaluate the efficacy of IL-1 blockers in a cohort of patients with colchicine-resistant familial Mediterranean fever (crFMF) treated consecutively with anakinra and canakinumab.Patients with crFMF treated with anakinra and canakinumab in any orde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0ebb25e7f3b4598725d30e78ce7fa64
https://doi.org/10.55563/clinexprheumatol/rrr9zd
https://doi.org/10.55563/clinexprheumatol/rrr9zd
Autor:
Liran Shechtman, Karney Lahad, Avi Livneh, Chagai Grossman, Amit Druyan, Eitan Giat, Merav Lidar, Sarit Freund, Uri Manor, Alon Pomerantz, Daniel Veroslavski, Ilan Ben-Zvi
Publikováno v:
Rheumatology (Oxford, England). 61(SI2)
Objectives Evidence suggests a possible association between the COVID-19 vaccine and autoimmune disease flares or new onset of various autoinflammatory manifestations, such as pericarditis and myocarditis. The objective of this study was to assess th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dc1ebbf4c8aade4db4b979d06340029
https://pubmed.ncbi.nlm.nih.gov/35238382
https://pubmed.ncbi.nlm.nih.gov/35238382
Publikováno v:
Journal of general internal medicine. 37(13)
The CHA2DS2-VASC score is used to assess the risk of cerebrovascular accident (CVA) in patients with atrial fibrillation (AF) or atrial flutter (AFL).We aimed to determine whether this score can determine the risk of CVA during the first year after h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::441adaa48b25acb436cb015e898e3a3d
https://pubmed.ncbi.nlm.nih.gov/35622270
https://pubmed.ncbi.nlm.nih.gov/35622270
Autor:
Howard Amital, Amit Druyan, Yehuda Shoenfeld, Leonard H. Calabrese, Muhanad Abu Elhija, Gabriele De Marco, Hussein Mahajna, Devy Zisman, Edward M Vital, Nizar Hijazi, Muna Elias, Michal Brodavka, A. Haddad, Abdulla Watad, Dennis McGonagle, Charlie Bridgewood, Joanna McLorinan, Nicola Luigi Bragazzi, Pnina Langevitz, Mailam Eltity, Arsalan Abu-Much, Merav Lidar, Helena Marzo-Ortega, Yael Cohen, Mohammad E. Naffaa, Cassandra Calabrese
Publikováno v:
Vaccines
Volume 9
Issue 5
Vaccines, Vol 9, Iss 435, p 435 (2021)
Volume 9
Issue 5
Vaccines, Vol 9, Iss 435, p 435 (2021)
Background: Infectious diseases and vaccines can occasionally cause new-onset or flare of immune-mediated diseases (IMDs). The adjuvanticity of the available SARS-CoV-2 vaccines is based on either TLR-7/8 or TLR-9 agonism, which is distinct from prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3213fe69cef6be745865fa47f7ec3d79
Publikováno v:
Acta radiologica (Stockholm, Sweden : 1987). 63(3)
Background Takayasu arteritis (TA), a systemic large-vessel vasculitis, was reported to have high incidence of spondyloarthropathy. Purpose To evaluate the prevalence of inflammatory sacroiliitis in patients with TA that underwent abdominal/pelvic ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a6423831189b135459a69124242acba
https://pubmed.ncbi.nlm.nih.gov/33843285
https://pubmed.ncbi.nlm.nih.gov/33843285
Autor:
Asaf, Levartovsky, Rami, Gilead, Amir, Sharon, Adam, Pomeranz, Amit, Druyan, Gal, Westrich, Robert K, Huber, Haim, Mayan, Noya, Shilo
Publikováno v:
The Israel Medical Association journal : IMAJ. 23(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::48477eef17c42b323f6f38f14f391e1b
https://pubmed.ncbi.nlm.nih.gov/33443348
https://pubmed.ncbi.nlm.nih.gov/33443348
Publikováno v:
Dermatologic Therapy
Data regarding the risk for severe COVID19 in patients with autoimmune or inflammatory diseases are scarce. To estimate the risk of those patients to develop a more severe COVID19 infection All active patients and those with dermatologic and/or rheum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9919e276e18e6708085aca45d1b2517
https://doi.org/10.1111/dth.14627
https://doi.org/10.1111/dth.14627
Autor:
Merav Lidar, Chagai Grossman, Shaye Kivity, Limor Marko, Asaf Shemer, Avi Livneh, Amit Druyan
Publikováno v:
Rheumatology (Oxford, England). 60(6)
Objective FMF is an autoinflammatory disease of genetic origin. Colchicine is the mainstay of treatment for the prevention of attacks and long-term complications but 5–10% of FMF patients are resistant to colchicine therapy. The aim of our study wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac0e7cde8d4c02ccffcfffc1066f766f
https://pubmed.ncbi.nlm.nih.gov/34144604
https://pubmed.ncbi.nlm.nih.gov/34144604